Genentech Inc. alerted eye doctors late last week to the risk of stroke from Lucentis. The drug is used to treat age related macular degeneration. According to AHAF, Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina, the paper-thin tissue at the back of the eye where light-sensitive cells send visual signals to the brain.
The company will probably change the drug label soon.
